Wang C, Zhao K, Hu S, Dong W, et al. Clinical Outcomes of Afatinib Versus Osimertinib in Patients With Non-Small Cell Lung Cancer With Uncommon EGFR Mutations: A Pooled Analysis. Oncologist 2023 Apr 28:oyad111. doi: 10.1093.
PMID: 37116899